ESMO 2025 – Dr. Kalinsky on Key Breast Trials

Dr. Kevin Kalinsky shares his perspective on the most significant breast cancer data from ESMO 2025, including updates from NATALEE, monarchE, DESTINY-Breast05 & 11, ASCENT-03, and TROPION-Breast02—highlighting key findings shaping treatment practice.